1.Fisher, B, Anderson, S, Bryant, Jet al. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233–1241.
2.Veronesi, U, Cascinelli, N, Mariani, Let al. Twenty-year follow-up of a randomised study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2000; 347: 1227–1232.
3.Van Dongen, J A, Voogd, A C, Fentiman, I Set al. Long term results of a randomised trial comparing breast-conserving therapy with mastectomy: European Organisation for Research and Treatment of Cancer 10,801 trial. J Natl Cancer Inst 2000; 92: 1143–1150.
4.Al-Rahbi, Z S, Al Mandhari, Z, Ravichandran, Ret al. Dosimetric comparison of intensity modulated radiotherapy isocentric field plans and field in field (FIF) forward plans in the treatment of breast cancer. J Med Phys 2013; 38: 22–29.
5.Trombetta, M, Julian, T B, Valakh, Vet al. Reduction in radiation-induced morbidity by use of an intercurrent boost in the management of early-stage breast cancer. Int J Radiat Oncol Biol Phys 2010; 77: 1303–1308.
6.Zelefsky, M J, Fuks, Z, Happersett, Let al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000; 55: 241–249.
7.Longobardi, B, De Martin, E, Fiorino, Cet al. Comparing 3DCRT and inversely optimised IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques. Radiother Oncol 2005; 77: 148–156.
8.Pignol, J, Olivotto, I, Rakovitch, Eet al. Phase III randomised study of intensity modulated radiation therapy versus standard wedging technique for adjuvant breast radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: 2085–2092.
9.Donovan, E, Bleakley, N, Denholm, Eet al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007; 82: 254–264.
10.Harsolia, A, Kestin, L, Grillis, Iet al. Intensity modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 1375–1380.
11.Freedman, G M, Anderson, P R, Li, Jet al. Intensity Modulated Radiation Therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol 2006; 29: 66–70.
12.Hall, E J, Wuu, C-S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83–88.
13.Zhang, F, Zheng, M. Dosimetric evaluation of conventional radiotherapy, 3D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery. J Med Imaging Radiat Oncol 2011; 55: 595–602.
14.Mansouri, S, Naim, A, Glaria, L, Marsiglia, H. Dosimetric evaluation of 3-D conformal and intensity-modulated radiotherapy for breast cancer after conservative surgery. Asian Pac J of Cancer Prev 2014; 15: 4727–4732.
15.Abeyaratne, D. Can intensity modulated radiation therapy reduce cardiac dose in left-sided breast patients. Radiographer 2010; 57: 40–44.
16.Ahunbay, E E, Chen, G P, Thatcher, Set al. Direct aperture optimisation-based intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys 2007; 67: 1248–1258.
17.Descovich, M, Fowble, B, Bevan, A, Schechter, N, Park, C, Xia, P. Comparison between hybrid direct aperture optimised intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys 2010; 76: 91–99.
18.Mayo, C S, Urie, M M, Fitzgerald, T J. Hybrid IMRT plans—concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. Int J Radiat Oncol Biol Phys 2005; 61: 922–932.
19.Farace, P, Zucca, S, Solla, Iet al. Planning hybrid intensity modulated radiation therapy for whole-breast irradiation. Int J Radiat Oncol Biol Phys 2012; 84: e115–e122.
20.Peulen, H, Hanbeukers, B, Boersma, Let al. Forward intensity-modulated radiotherapy planning in breast cancer to improve dose homogeneity: feasibility of class solutions. Int J Radiat Oncol Biol Phys 2012; 82: 394–400.
21.Hurkmans, C W, Meijer, G J, van Vliet-Vroegindeweij, Cet al. High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimisation. Int J Radiat Oncol Biol Phys 2006; 66: 923–930.
22.Offersen, B V, Boersma, L J, Kirkove, Cet al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 2015; 114: 3–10.
23.Jameson, M G, Holloway, L C, Vial, P J, Vinod, S K, Metcalfe, P E. A review of methods of analysis in contouring studies for radiation oncology. J Med Imaging Radiat Oncol 2010; 54: 401–410.
24.Feuvret, L, Noel, G, Mazeron, J J, Bey, P. Conformity index—a review. Int J Radiat Oncol Biol Phys 2006; 64: 333–342.
25.Kataria, T, Sharma, K, Subramani, V, Karrthick, K P, Bisht, S S. Homogeneity index: an objective tool for assessment of conformal radiation treatments’. J Med Phys 2012; 34: 207–213.
26.ICRU. International Commission on Radiation Units and Measurements; Prescribing recording and reporting photon-beam intensity-modulated Radiation Therapy (IMRT), ICRU Report 83. J ICRU 2010; 10: 1–106.
27.Marks, L B, Bentzen, S M, Deasy, J Oet al. QUANTEC: organ specific paper, thorax: lung, radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010; 76: S70–S76.
28.Xie, X, Ouyang, S, Wang, Het al. Dosimetric comparison of left-sided whole breast irradiation with 3D-CRT, IP-IMRT and hybrid IMRT. Oncol Rep 2014; 31: 2195–2205.
29.Shiau, A, Hsieh, C, Tien, Het al. Left-sided whole breast irradiation with hybrid-IMRT and helical tomotherapy dosimetric comparison. BioMed Res Int 2014; 2014: Article ID 741326. doi:10.1155/2014/741326.
30.Gagliardi, G, Constine, L S, Moiseenko, Vet al. QUANTEC: organ specific paper, thorax: heart, radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010; 76: S77–S85.
31.Darby, S C, Ewertz, M, McGale, Pet al. Risk of ischemic heart disease in women dafter radiotherapy for breast cancer. N Eng J Med 2013; 368: 987–998.
32.Henson, K E, McGale, P, Taylor, C, Darby, S C. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer 2013; 108: 179–182.
33.Correa, C R, Das, I J, Litt, H Iet al. Association between tangential beam treatment parameters and cardiac abnormalities after definitive radiation treatment for left-sided breast cancer. Int J Radiat Oncol Biol Phys 2008; 72: 508–516.
34.Darby, S C, McGale, P, Taylor, C W, Peto, R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005; 6: 557–565.
35.Lind, P A, Pagnanelli, R, Marks, L Bet al. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys 2003; 55: 914–920.
36.Evans, E S, Prosnitz, R G, Yu, Xet al. Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer. Int J Radiat Oncol Biol Phys 2006; 66: 1125–1134.
37.Guerrero, M, Li, X A, Earl, M A, Safraraz, M, Kiggundu, E. Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study. Int J Radiat Oncol Biol Phys 2004; 59: 1513–1522.
38.Korreman, S S, Pedersen, A N, Aarup, L R, Nottrup, T J, Specht, L, Nystrom, H. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 2006; 65: 1375–1380.
39.Sung, K, Lee, K C, Lee, S H, Ahn, S H, Lee, S H, Choi, J. Cardiac dose reduction with breathing adapted radiotherapy using self respiration monitoring system for left-sided breast cancer. Radiat Oncol J 2014; 32: 84–94.
40.Swanson, T, Grills, I, Ye, Het al. Six-year experience routinely utilising moderate deep inspiration breath-hold (MDIBH) for the reduction of cardiac dose in left-sided breast irradiation for patients with early stage or locally advanced breast cancer. Am J Clin Oncol 2013; 36: 24–30.
41.Williams, T N, Moran, J M, Hsu, H Set al. Contralateral breast dose after whole-breast irradiation: an analysis by treatment technique. Int J Radiat Oncol Biol Phys 2012; 82: 2079–2085.
42.Woo, T C S, Pignol, J P, Rakovitch, Eet al. Body radiation exposure in breast cancer radiotherapy: impact of breast IMRT and virtual wedge compensation techniques. Int J Radiat Oncol Biol Phys 2006; 65: 52–58.
43.Fernando, I N, Ford, H T, Powles, T Jet al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the royal Marsden hospital. Clin Oncol (R Coll Radiol) 1996; 8: 226–233.
44.Vicini, F A, Sharpe, M, Kestin, Let al. Optimising breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002; 54: 1336–1344.
45.Johansson, S, Svensson, H, Denekamp, J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 2002; 52: 1207–1219.
46.Pignol, J, Olivotto, I, Rakovitvh, Eet al. A multicentre randomised trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26: 2085–2092.
47.Back, M, Guerrieri, M, Wratten, C, Steigler, A. Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer. J Clin Oncol 2004; 16: 12–13.
48.Mihai, A, Rakovitch, E, Sixel, Ket al. Inverse vs. forward breast IMRT planning. Med Dosim 2005; 30: 149–154.
49.Schubert, L K, Gondi, V, Sengbusch, Eet al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT helical tomotherapy, and topotherapy. Radiother Oncol 2011; 100: 241–246.
50.Singla, R, King, S, Albuquerque, K, Creech, S, Dogan, N. Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma. Med Dosim 2006; 31: 190–196.
51.Small, K, Kelly, C, Beldham-Collins, R, Gebski, V. Whole breast and excision cavity radiotherapy plan comparison: conformal radiotherapy with sequential boost versus intensity-modulated radiation therapy with a simultaneously integrated boost. J Med Radiat Sci 2012; 60: 16–24.
52.Bartelink, H, Maingon, P, Poortmans, Pet al. On behalf of the European organisation for research and treatment of cancer radiation oncology and breast cancer groups, whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet 2015; 16: 47–56.
53.Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087–2106.
54.Freedman, G M, Anderson, P R, Bleicher, R Jet al. Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer. Int J Radiat Oncol Biol Phys 2012; 84: 888–893.